These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 4295707)

  • 21. [Effect of angiotensin on cirrhotics].
    Galea G; Varlas A; Bucur G
    Med Interna (Bucur); 1972 May; 24(5):515-9. PubMed ID: 4340437
    [No Abstract]   [Full Text] [Related]  

  • 22. Interaction between the natriuretic effects of renal perfusion pressure and the antinatriuretic effects of angiotensin and aldosterone in control of sodium excretion.
    Young DB; Pan YJ
    J Physiol (Paris); 1984; 79(6):511-7. PubMed ID: 6399318
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies on the sites of action of ethacrynic acid and furosemide during angiotensin infusion.
    Rado JP; Szende L; Tako J; Borbely L
    J Clin Pharmacol J New Drugs; 1970; 10(6):375-81. PubMed ID: 4320100
    [No Abstract]   [Full Text] [Related]  

  • 24. [The influencing of kidney function with mannitol infusions in acute and chronic renal insufficiency].
    Scheler F; Quellhorst E; Höffler D; Wigger W
    Schweiz Med Wochenschr; 1965 Aug; 95(34):1133-40. PubMed ID: 5843208
    [No Abstract]   [Full Text] [Related]  

  • 25. [Experience in the treatment of water-salt retentions in cirrhosis by the antialdosterone 11614 R.P].
    Boivin P; Fauvert R
    Rev Int Hepatol; 1969; 19(4):241-51. PubMed ID: 5404532
    [No Abstract]   [Full Text] [Related]  

  • 26. [Intrarenal effects of angiotensin II].
    Salvetti A; Arzilli F; Russo R
    Minerva Nefrol; 1971; 18(3):139-50. PubMed ID: 4329942
    [No Abstract]   [Full Text] [Related]  

  • 27. Reversal of atrial natriuretic peptide resistance by increasing distal tubular sodium delivery in patients with decompensated cirrhosis.
    Abraham WT; Lauwaars ME; Kim JK; Peña RL; Schrier RW
    Hepatology; 1995 Sep; 22(3):737-43. PubMed ID: 7657277
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of single oral low-dose losartan on posture-related sodium handling in post-TIPS ascites-free cirrhosis.
    Therapondos G; Hol L; Benjaminov F; Wong F
    Hepatology; 2006 Sep; 44(3):640-9. PubMed ID: 16941706
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club.
    Arroyo V; Ginès P; Gerbes AL; Dudley FJ; Gentilini P; Laffi G; Reynolds TB; Ring-Larsen H; Schölmerich J
    Hepatology; 1996 Jan; 23(1):164-76. PubMed ID: 8550036
    [No Abstract]   [Full Text] [Related]  

  • 30. Renal concentrating ability in cirrhosis. I. Changes associated with the clinical status and course of the disease.
    Vaamonde CA; Vaamonde LS; Morosi HJ; Klingler EL; Papper S
    J Lab Clin Med; 1967 Aug; 70(2):179-94. PubMed ID: 6029052
    [No Abstract]   [Full Text] [Related]  

  • 31. Use of a new diuretic agent (metolazone) in patients with edema and ascites.
    Lowenthal DT; Shear L
    Arch Intern Med; 1973 Jul; 132(1):38-41. PubMed ID: 4716425
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effect of low-dose angiotensin II on urinary function in waking adrenalectomized dogs].
    Ader JL; Geral JP
    C R Seances Soc Biol Fil; 1973; 167(3):541-3. PubMed ID: 4361799
    [No Abstract]   [Full Text] [Related]  

  • 33. Protective effect of sucrose and mannitol against vasoconstriction induced by angiotensin II in the kidney.
    Kövér G; Harza T; Mályusz M; Szöcs E
    Acta Physiol Acad Sci Hung; 1968; 33(1):19-26. PubMed ID: 4297888
    [No Abstract]   [Full Text] [Related]  

  • 34. Interactions between acute effect of angiotensin converting enzyme inhibition and salt balance on the renal function and urinary prostanoids. Studies in healthy women.
    Agnoli GC; Borgatti R; Cacciari M; Garutti C; Ikonomu E; Lenzi P; Marinelli M; Stipo L
    Boll Soc Ital Biol Sper; 1996; 72(3-4):117-24. PubMed ID: 8771912
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect of theophylline on the kidney].
    Vlasov VV
    Farmakol Toksikol; 1970; 33(6):697-9. PubMed ID: 5518490
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effect of ethacrynic acid on diuresis, electrolyte excretion, and renal function in cases of liver cirrhosis].
    Koçak N; Ozdoğan E
    Turk Tip Cemiy Mecm; 1968; 34(8):502-10. PubMed ID: 5732894
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of angiotensin II on urinary sodium excretion in normal subjects and in cirrhotic patients.
    Ajzen H; Andrade U; Cipullo JP; Sustovich DR; Ramos OL
    Am J Med Sci; 1968 Dec; 256(6):373-9. PubMed ID: 4302904
    [No Abstract]   [Full Text] [Related]  

  • 38. Impairment of renal function during moderate physical exercise in cirrhotic patients with ascites: relationship with the activity of neurohormonal systems.
    Saló J; Guevara M; Fernández-Esparrach G; Bataller R; Ginès A; Jimenez W; Ginès P; Rivera F; Arroyo V; Rodés J
    Hepatology; 1997 Jun; 25(6):1338-42. PubMed ID: 9185749
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pathogenesis and therapy of ascites in liver cirrhosis].
    Dölle W
    Internist (Berl); 1966 Jan; 7(1):48-54. PubMed ID: 4861685
    [No Abstract]   [Full Text] [Related]  

  • 40. [Function test of renal excretion of water and sodium after water loading in liver cirrhosis].
    Giudici Cipriani A; Richeri F; Falchero M; Colombo P; Bertolazzi R; Folco U; Marenco G
    Minerva Med; 1983 Jun; 74(27):1629-34. PubMed ID: 6856172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.